Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML
Bing Z. Carter, Wenjing Tao, Po Yee Mak, Lauren B. Ostermann, Duncan H. Mak, Gerard M. McGeehan, Peter Ordentlich, Michael Andreeff
Topics & Concepts
VenetoclaxNPM1Cancer researchAzacitidineMutationHematologic NeoplasmsLeukemiaMedicineBiologyGeneticsInternal medicineTransplantationChronic lymphocytic leukemiaGeneKaryotypeDNA methylationGene expressionChromosomeAcute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesProtein Degradation and Inhibitors